Cholesterol-lowering therapy for smokers

被引：0
|
作者：
Jackson, PR [1 ]
机构：
[1] Univ Sheffield, Royal Hallamshire Hosp, Sect Clin Pharmacol & Therapeut, Sheffield S10 2JF, S Yorkshire, England
来源：
LANCET | 2001年 / 357卷 / 9260期
关键词：
D O I：
10.1016/S0140-6736(05)71661-5
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：960 / 960
页数：1
相关论文
共 50 条
  • [1] Cholesterol-lowering therapy for smokers and non-smokers: a life-table analysis
    Bonneux, L
    [J]. LANCET, 2000, 356 (9246): : 2004 - 2006
  • [2] Cholesterol-lowering therapy - Response
    Matsuoka, H
    Tamai, O
    Imaizumi, T
    [J]. CIRCULATION, 1997, 96 (10) : 3801 - 3802
  • [3] Pharmacogenomics of cholesterol-lowering therapy
    Schmitz, G
    Langmann, T
    [J]. VASCULAR PHARMACOLOGY, 2006, 44 (02) : 75 - 89
  • [4] Need to individualise cholesterol-lowering therapy
    Luetjohann, Dieter
    Weingaertner, Oliver
    [J]. HEART, 2019, 105 (16)
  • [5] Appropriate use of cholesterol-lowering therapy
    Falk, Erling
    [J]. ATHEROSCLEROSIS, 2017, 262 : 198 - 199
  • [6] The future direction of cholesterol-lowering therapy
    Evans, M
    Roberts, A
    Rees, A
    [J]. CURRENT OPINION IN LIPIDOLOGY, 2002, 13 (06) : 663 - 669
  • [7] Pharmacogenetics and pharmacogenomics of cholesterol-lowering therapy
    Schmitz, Gerd
    Schmitz-Madry, Anna
    Ugocsai, Peter
    [J]. CURRENT OPINION IN LIPIDOLOGY, 2007, 18 (02) : 164 - 173
  • [8] Cholesterol-lowering therapy: Is there really a controversy?
    Jungnickel, PW
    [J]. ANNALS OF PHARMACOTHERAPY, 1996, 30 (05) : 539 - 542
  • [9] Pleiotropic Effects and Cholesterol-Lowering Therapy
    Shaw, Steven M.
    Fildes, James E.
    Yonan, Nizar
    Williams, Simon G.
    [J]. CARDIOLOGY, 2009, 112 (01) : 4 - 12
  • [10] Pharmacogenomics and pharmacogenetics of cholesterol-lowering therapy
    Schmitz, G
    Drobnik, W
    [J]. CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2003, 41 (04) : 581 - 589
12345